Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects

NCT01975636 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT01975636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01975636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects
Lead sponsor
Eisai Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2013
Completion date
March 31, 2014
Enrollment
113 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolism and elimination